Skip to main content

Table 3 Biochemical changes following SWL (n = 12)

From: Shock wave lithotripsy, for the treatment of kidney stones, results in changes to routine blood tests and novel biomarkers: a prospective clinical pilot-study

 

Baseline

30 min

120 min

240 min

Reference range

p value

Statistical test

CRP (mg/L)

3.1 (± 1.0/8.0)

1.65 (± 1.0/7.0)

1.8 (± 1.0/7.5)

1.9 (± 1.0/6.40)

0–5.0

0.101

Friedman

Total protein (g/L)

71.33 ± 4.83

67.93 ± 4.23*

64.45 ± 3.45*

67.64 ± 3.03*

60.0–80.0

< 0.001

ANOVA

Albumin (g/L)

43.13 ± 3.0

40.90 ± 3.12*

39.33 ± 3.5*

40.77 ± 3.22

35.0–45.0

< 0.001

ANOVA

Globulin (g/L)

28 (± 25/37)

28 (± 22/30)

26 (± 23/27)*

26.5 (± 25/30)

23.0–35.0

0.006

Friedman

Total bilirubin (µmol/L)

13.5 (± 7/23)

15 (± 7/22)

12 (± 9/43)

11 (± 8/22)

< 21

0.140

Friedman

Alkaline phosphatase—ALP (U/L)

73 (± 36/91)

65 (± 37/93)*

68.5 (± 35/85)*

72.5 (± 34/86)

30.0–130.0

0.018

Friedman

Alkaline transaminase—ALT (U/L)

35.5 (± 18/70)

34 (± 18/65)

35 (± 17/62)

37 (± 15/67)*

< 41 (male)

< 33 (female)

0.01

Friedman

Urea (mmol/L)

4.90 (± 2.7/6.0)

4.80 (± 2.8/6.0)

4.90 (± 3.6/5.20)

4.85 (± 3.30/5.20)

2.5–7.8

0.478

Friedman

Creatinine (µmol/L)

67.1 (± 11.39)

69.7 (± 13.04)

73.0 (± 12.30)

71.1(± 14.09)

M: 58.0–110.0

F: 46.0–92.0

0.365

ANOVA

Sodium (mmol/L)

140 (± 135/140)

139 (± 132/143)*

137 (± 134/142)*

138 (± 133/140)*

135.0–146.0

0.010

Friedman

Potassium (mmol/L)

4.27 (± 3.9/4.6)

4.37 (± 3.64/4.60)

4.12(± 3.4/5.0)

4.2 (± 3.8/4.60)

3.5–5.3

0.291

Friedman

  1. Statistical significance following post hoc analysis is represented when *p ≤ 0.05. (M, male; F, female)